Cephalalgia

Article	Citations
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	112
Evidence-based guidelines for the pharmacological treatment of migraine	91
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	90
Harassment in the headache field: a global web-based cross-sectional survey	84
International Classification of Headache Disorders-4 – Work in Progress 1	69
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	66
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	57
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	52
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	49
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	46
Call for papers	46
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	37
Systemic lupus erythematosus mimicking retinal migraine: a case report	36
An altered reward system characterizes chronic migraine with medication overuse headache	36
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	36
Depression screening in migraine - A double-edged sword	35
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	35
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	33
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	32
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	32
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	31
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	31
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	31
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	30

Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	30
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	29
Looking at Cephalalgia from the inside	29
Comorbidity or combination – more evidence for cluster-migraine?	29
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	29
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	28
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	27
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	27
What is the evolutionary disadvantage of migraine?	26
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	25
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	25
Sex differences in photophobic behaviors following cortical spreading depression in rats	25
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	24
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	24
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	24
Genome sequencing reveals the Adgrl3 ( ADGRL3 ) gene as a possible cause of cephalic hypersensitivity in the STA rat and migraine in human	24
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	24
The midfacial segment pain: little known disorder in need of scientific evaluation	24
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	23
Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study	23
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	23
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	23
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	23
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	21
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	21
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks	21
Abstracts from the International Headache Congress 14–17 September 2023	20
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	19
Thanks to Reviewers	19
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study	19
Burden of headache in a HIV-positive population of sub-Saharan Africa	19
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex	18
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	18
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	18
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adu	18
Plasma adrenomedullin levels in migraine: A registry for migraine (REFORM) study	18
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	18
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	18
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	17
Internet and social media's role in migraine education: Headache or not headache?	17
The “index vein” as a sign for migraine aura in the emergency setting	17
Are we closer to achieving precision medicine for migraine treatment? A narrative review	17
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	17
Erratum	17
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	16
The impact of eating disorders on idiopathic intracranial hypertension	16
Shared genetics and causal relationships between migraine and thyroid function traits	16
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	16
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study	16
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	16

Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	15
Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic migraine on flunarizine: Prospective proof-of-concept study	15
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	15
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	15
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	15
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	15
Avoidance behaviour modulates but does not condition phonophobia in migraine	14
Hypnic Headache – What do we know in 2022?	14
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	14
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	14
Headache at the chronic stage of cerebral venous thrombosis	14
Prevalence of neck pain in migraine: A systematic review and meta-analysis	14
Premonitory symptoms in migraine: A REFORM Study	14
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	14
Board Walk – April 2022	14
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	14
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America	14
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	13
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	13
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	13
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	13
Proposed general diagnostic criteria for secondary headaches	13
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	13
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	13
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	13
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	12
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	12
Late Breaking Author Index	12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	12
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	12
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
Other primary headaches: Distinct clinical features and uncertain pathophysiology	12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	12
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	12
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	12
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	12
Cephalalgia: a legacy of excellence, a vision for tomorrow	12
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	12
Epicranial headaches part 2: Nummular headache and epicrania fugax	11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	11
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	11
Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache	11
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	11
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	11
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	11
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	11
The psychometric properties of an e-headache diary in migraine	11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	11
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	11
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	11
Personal view: Modelling pain mechanisms of migraine without aura	10
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	10
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic	10
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	10
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study	10
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	10
Headache provocation by nitric oxide in men who have never experienced a headache	10
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	10
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	10
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	10
Multidisciplinary headache treatment with work-focus in Norway: An observational study	10
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	10
Lack of a direct link between macular cones function and photophobia in interictal migraine	10
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	10
It is a long way to the top if you wanna citations?	9
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine	9
A narrative review of app- and internet-delivered headache interventions: From ideation to implementation and the future	9
Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis	9
Functional magnetic resonance imaging in migraine: A systematic review	9
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea	9
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	9
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	9
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	9
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study	9
Update on cough, exertional and sex headache	9
Reviewing the complex relationship between circadian rhythms and cluster headache	9
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura	9
A systematic evaluation of primary headache management apps leveraging behavior change techniques	9
Update in the understanding of new daily persistent headache	9

Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	9
Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction	9
ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache	9
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two	9
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine	9
Visual snow syndrome is probably not mediated by CGRP: A case series	9
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	9
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	9
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype	9